Condition
    Moderate Evidence
    Effectiveness 3/5

    Iron for Restless Legs Syndrome

    Iron is not just a supplement option for RLS — guidelines make it first-line treatment when ferritin is low, with trials showing genuine symptom reduction even when standard blood counts are normal.

    Overview

    Restless legs syndrome is one of the few conditions where iron is a mainstream first-line treatment rather than a supplement afterthought. A 2019 Cochrane review of iron for the treatment of restless legs syndrome found evidence that iron improves symptom severity. A 2017 Movement Disorders randomised trial of intravenous ferric carboxymaltose in patients with RLS and non-anaemic iron deficiency showed benefit even without anaemia.
    That non-anaemic finding is central. Brain iron can be low while blood iron looks acceptable, which is why RLS guidelines use a much higher ferritin target than general medicine, commonly above 75 micrograms per litre. Oral iron works for many people but absorption is slow and hepcidin-limited; intravenous iron is used where oral fails or ferritin is very low. Iron is not a cure and does not help everyone, but it addresses an underlying mechanism rather than only masking symptoms.

    How It Works

    RLS is fundamentally a brain iron problem. Autopsy, cerebrospinal fluid and MRI studies consistently show reduced iron in the substantia nigra and other regions in people with RLS, even when peripheral iron stores are normal, pointing to impaired iron transport across the blood-brain barrier. Iron is the cofactor for tyrosine hydroxylase, the rate-limiting enzyme in dopamine synthesis, which links iron status directly to the dopaminergic dysfunction characteristic of the condition.
    Low brain iron also alters D2 receptor density and disrupts the descending dopaminergic pathways that modulate spinal sensory and motor circuits, which fits the sensory discomfort and urge to move that define RLS. The circadian pattern, with symptoms worst in the evening and at night, mirrors the natural nocturnal dip in dopamine and in serum iron. Raising systemic iron sufficiently and for long enough can increase brain iron, which is why repletion targets are higher and treatment periods longer than for anaemia.

    Dosing & Protocol

    Guidelines commonly use 65 mg elemental iron as ferrous sulphate with 100 to 200 mg vitamin C, taken on alternate days on an empty stomach where tolerated. Alternate-day dosing improves fractional absorption by limiting the hepcidin rise. Evening dosing is often suggested to align with the nocturnal iron dip. The target ferritin is above 75 micrograms per litre with transferrin saturation above 20 percent. Allow three months before judging, and retest rather than guessing.

    The RLS ferritin target is higher than normal

    A ferritin of 40 might be called normal by a lab but is too low for restless legs. Guidelines aim above 75 micrograms per litre.

    Evidence

    Two linked studies support this pairing: a 2019 Cochrane review of iron for the treatment of restless legs syndrome, and a 2017 Movement Disorders randomised trial of ferric carboxymaltose in patients with RLS and non-anaemic iron deficiency. The Cochrane review found iron improves RLS severity while noting that the trials are mostly small and heterogeneous in route, dose and iron status at entry. The Movement Disorders trial is the key evidence that benefit does not require anaemia.

    Studies linked to this pairing.

    Ferric carboxymaltose in patients with restless legs syndrome and nonanemic iron deficiency: A randomized trial

    Score: 7/10
    2017
    rct
    n=110

    Trenkwalder C

    In patients who responded to treatment, ferric carboxymaltose may require more time to stabilize restless legs syndrome than previously assumed.

    View source

    Iron for the treatment of restless legs syndrome

    Score: 9/10
    2019
    systematic_review
    n=428

    Trotti LM, Becker LA

    Iron therapy probably improves restlessness and RLS severity in comparison to placebo.

    View source

    Safety

    Oral iron commonly causes constipation, nausea and black stools, particularly on an empty stomach, which is exactly how RLS protocols suggest taking it. Alternate-day dosing and bisglycinate improve tolerability. Intravenous iron avoids gut effects but carries a small risk of hypersensitivity reactions and must be given in a supervised setting. The universal caution applies: do not supplement without measuring iron status, since accumulation is harmful and haemochromatosis may be undiagnosed.

    Watch for augmentation on dopamine agonists

    If you take a dopamine agonist and symptoms start earlier in the day, spread to the arms or intensify, this may be augmentation. It needs prompt specialist review, not a dose increase.

    Interactions & Conflicts

    Several common medications worsen RLS and can undo the benefit of iron repletion: sedating antihistamines, dopamine-blocking antiemetics such as metoclopramide, most antipsychotics, and many antidepressants, particularly SSRIs and SNRIs. Iron itself blocks absorption of levothyroxine, tetracyclines, quinolones and levodopa, needing four-hour separation, while calcium, tea, coffee and proton pump inhibitors reduce iron uptake.
    Interacts withSeverityMechanismAction
    high
    		——
    high
    		——
    moderate
    		——
    high
    		——
    high
    		——
    moderate
    		——

    References

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.